Varicella zoster virus infection.
Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K.
Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16.
The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation.
Kennedy PGE.
Viruses. 2023 Jul 30;15(8):1663. doi: 10.3390/v15081663.
Spectrum of neurological complications following COVID-19 vaccination.
Garg RK, Paliwal VK.
Neurol Sci. 2022 Jan;43(1):3-40. doi: 10.1007/s10072-021-05662-9. Epub 2021 Oct 31.
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G.
Immunol Res. 2023 Jun;71(3):356-372. doi: 10.1007/s12026-023-09357-5. Epub 2023 Jan 6.
Neurological complications of varicella zoster virus reactivation.
Nagel MA, Gilden D.
Curr Opin Neurol. 2014 Jun;27(3):356-60. doi: 10.1097/WCO.0000000000000092.
Temporary Spinal Cord Stimulation for Herpes Zoster With Myelitis: A Case Series.
Kobayashi R, Taketomi A, Hara E, Mera H, Oe K.
Cureus. 2024 Mar 11;16(3):e55979. doi: 10.7759/cureus.55979. eCollection 2024 Mar.
Infectious myelopathies.
Berger JR, Sabet A.
Semin Neurol. 2002 Jun;22(2):133-42. doi: 10.1055/s-2002-36536.
Herpes zoster as a systemic disease.
Staikov I, Neykov N, Marinovic B, Lipozenčić J, Tsankov N.
Clin Dermatol. 2014 May-Jun;32(3):424-9. doi: 10.1016/j.clindermatol.2013.11.010. Epub 2013 Nov 22.
Herpes zoster myelitis.
Devinsky O, Cho ES, Petito CK, Price RW.
Brain. 1991 Jun;114 ( Pt 3):1181-96. doi: 10.1093/brain/114.3.1181.
Myelitis.
Andersen O.
Curr Opin Neurol. 2000 Jun;13(3):311-6. doi: 10.1097/00019052-200006000-00014.
